← Back to Clinical Trials
Recruiting NCT06445530

NCT06445530 Nutrition Optimization and Community Upliftment for Postpartum Recovery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06445530
Status Recruiting
Phase
Sponsor Johns Hopkins University
Condition Obesity, Maternal
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2025-09-15
Primary Completion 2027-03

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
MFeast ENHANCEDMFeast Usual Care

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 40 participants in total. It began in 2025-09-15 with a primary completion date of 2027-03.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to better understand how different strategies, timing, and enhancements to medically tailored food delivery will address structural inequities in the food environment, empower communities to sustain behavior change, and ultimately improve postpartum weight control to prevent type 2 diabetes-a potent contributor to disparate mortality among Black women. The main aims of the study are: * To conduct a pilot randomized control trial to test the feasibility, acceptability, and effectiveness of a multi-component Medically Tailored Food (MTF) intervention, Moveable Feast ENHANCED (a hybrid MTF intervention with a patient-activated change from prepared meals to fresh food delivery, customized for postpartum people, culturally customized for engagement and adherence, and food provision for dependents) versus MFeast Usual Care (prepared medically tailored foods only) * To test sustainability and scalability. Participants will: * Respond to online surveys (supported by study team members via scheduled phone calls) via REDCap links shared before each study visit at baseline, 3, 6 months post-delivery after the baseline survey. * Submit anthropometric data (i.e, weight) and information about laboratory results ( e.g. HgbA1C)

Eligibility Criteria

Inclusion Criteria: * Age ≥18 years * Self-identify as Black or African American * Low-income (defined as eligible for Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) benefits) * Speak English as a primary language * Identify as a primary meal planner/preparer * Gestational diabetes * Gestational age \>37 weeks * Have a BMI \> 30 (calculated based on chart review of height and weight measurement) * Willing to take part in the intervention and data collection procedures through online surveys Exclusion Criteria: * Mothers who have social support i.e. have family members preparing meals for the mother * Mothers who are unlikely to be at the primary residence in the postpartum period * Mothers with very specific dietary needs, i.e, food allergies, picky eaters, vegetarian / vegan * Mothers whose birth outcome is a stillborn * Mothers who have serious mental illness

Contact & Investigator

Central Contact

Michelle S Ogunwole, MD PhD

✉ sogunwo1@jhmi.edu

📞 2143154936

Principal Investigator

Michelle S Ogunwole, MD, PhD

PRINCIPAL INVESTIGATOR

Johns Hopkins School of Medicine

Frequently Asked Questions

Who can join the NCT06445530 clinical trial?

This trial is open to female participants only, aged 18 Years or older, studying Obesity, Maternal. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06445530 currently recruiting?

Yes, NCT06445530 is actively recruiting participants. Contact the research team at sogunwo1@jhmi.edu for enrollment information.

Where is the NCT06445530 trial being conducted?

This trial is being conducted at Baltimore, United States.

Who is sponsoring the NCT06445530 clinical trial?

NCT06445530 is sponsored by Johns Hopkins University. The principal investigator is Michelle S Ogunwole, MD, PhD at Johns Hopkins School of Medicine. The trial plans to enroll 40 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology